Sean P. Lyden, MD
Print Faculty Schedule:
|
SCHEDULE FOR VEITHsymposium™ |
Tuesday, November 19, 2024 |
Presenter
Is Transfemoral CAS Being Overused One Year After CMS Increased Reimbursement For Treating Asymptomatic Carotid Stenosis
9:02 AM - 9:07 AM
|
Wednesday, November 20, 2024 |
Presenter
3-Year Results With Percutaneous (PQ) Transvenous FemPop PTFE Bypasses Using The Torus 2 Endograft (From Endologix): How Is It Done And Updated Results From The US DETOUR Trial: Does It Have Limitations
2:43 PM - 2:48 PM
|
Presenter
Time To Perfusion In ALI: Which Is Faster, Lightning Bolt 7 (Penumbra) Or Open Surgical Embolectomy: When Is Open Surgery Necessary In 2024
5:52 PM - 5:57 PM
|
Presenter
Stellarex (Philips) DCBs With Low Dose Paclitaxel Is Safe And Has Higher Patency Rates Than POBA With De Novo Or Recurrent FemPop Lesions At 5 Years In The ILLUMENATE US And European RCTs
11:06 AM - 11:11 AM
|
Presenter
Transcaval Approach For Endoleak Embolization: A Minimally Invasive Hot Needle Approach And Other Technical Tips Including How To Close The Aortic Access Site
10:23 AM - 10:28 AM
|
Presenter
Vascular Surgery Needs An Independent ABMS Approved Board And Associated RRC To Thrive As A Specialty In The Medical Hierarchy And To Have Its Value Appropriately Recognized
2:30 PM - 2:35 PM
|
Thursday, November 21, 2024 |
Presenter
Status Of The Low Profile Alto Endograft (From Endologix) With More Proximal Polymer Sealing Rings For Standard EVAR: Up To 5-Year Results Show Its Advantages: Status Of The JAGUAR RCT Comparing It With Standard EVAR Endografts
8:24 AM - 8:29 AM
|
previous | next |